The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry
Abstract
To examine the overall state of metabolic control and current use of advanced diabetes technologies in the U.S., we report recent data collected on individuals with type 1 diabetes participating in the T1D Exchange clinic registry. Data from 16,061 participants updated between 1 September 2013 and 1 December 2014 were compared with registry enrollment data collected from 1 September 2010 to 1 August 2012. Mean hemoglobin A1c (HbA1c) was assessed by year of age from <4 to >75 years. The overall average HbA1c was 8.2% (66 mmol/mol) at enrollment and 8.4% (68 mmol/mol) at the most recent update. During childhood, mean HbA1c decreased from 8.3% (67 mmol/mol) in 2–4-year-olds to 8.1% (65 mmol/mol) at 7 years of age, followed by an increase to 9.2% (77 mmol/mol) in 19-year-olds. Subsequently, mean HbA1c values decline gradually until ∼30 years of age, plateauing at 7.5–7.8% (58–62 mmol/mol) beyond age 30 until a modest drop in HbA1c below 7.5% (58 mmol/mol) in those 65 years of age. Severe hypoglycemia (SH) and diabetic ketoacidosis (DKA) remain all too common complications of treatment, especially in older (SH) and younger patients (DKA). Insulin pump use increased slightly from enrollment (58–62%), and use of continuous glucose monitoring (CGM) did not change (7%). Although the T1D Exchange registry findings are not population based and could be biased, it is clear that there remains considerable room for improving outcomes of treatment of type 1 diabetes across all age-groups. Barriers to more effective use of current treatments need to be addressed and new therapies are needed to achieve optimal metabolic control in people with type 1 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Nathan, D. M., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2112 · Cited by 1,832
Continuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002853 · Cited by 894
SEARCH for Diabetes in Youth Study Group (2006) · Pediatrics · doi:10.1542/peds.2006-0690 · Cited by 726
Stockman, J. A. (2008) · Yearbook of Pediatrics · doi:10.1016/s0084-3954(08)70503-7 · Cited by 595
Miller, K. M., Beck, R. W., Bergenstal, R. M., Goland, R. S., Haller, M. J., McGill, J. B., Rodriguez, H., Simmons, J. H., Hirsch, I. B., & for the T1D Exchange Clinic Network (2013) · Diabetes Care · doi:10.2337/dc12-1770 · Cited by 505
Self-citationThe T1D exchange clinic registry
Beck, R. W., Tamborlane, W. V., Bergenstal, R. M., Miller, K. M., DuBose, S. N., Hall, C. A., & for the T1D Exchange Clinic Network (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1561 · Cited by 456
Self-citationAssociation between 7 years of intensive treatment of type 1 diabetes and long-term mortality
Orchard, T. J., Nathan, D. M., Zinman, B., Cleary, P., Brillon, D., Backlund, J.-Y. C., & Lachin, J. M. (2015) · JAMA · doi:10.1001/jama.2014.16107 · Cited by 437
Cited by
Sorted by citations
Items 901–1,000 of 1,002
Yaginuma, H., Banno, R., Sun, R., Taki, K., Mizoguchi, A., Kobayashi, T., Sugiyama, M., Tsunekawa, T., Onoue, T., Takagi, H., et al. (2021) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2021.08.010 · Cited by 6
Marr, A., Tsampalieros, A. K., Courtney, J. M., Hamid, J. S., St-Denis-Murphy, J., Stevens, L., Ahmet, A. H., & Goldbloom, E. B. (2022) · BMJ Open Quality · doi:10.1136/bmjoq-2021-001563 · Cited by 6
Silva, V. B., Fonseca, L., Duarte, D. B., Puga, F. M., Assuncao, G., Garrido, S., Teixeira, S., Vilaverde, J., & Cardoso, M. H. (2023) · Endocrine Regulations · doi:10.2478/enr-2023-0018 · Cited by 5
Dayton, K. A., & Silverstein, J. H. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.08.077 · Cited by 5
Primum Non Nocere: Refocusing Our Attention on Severe Hypoglycemia Prevention
Kahkoska, A. R., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0020 · Cited by 5
Bratke, H., Lønning, K. J., & Sivertsen, B. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13119 · Cited by 5
Zhou, Y., Deng, H., Liu, H., Yang, D., Xu, W., Yao, B., Yan, J., & Weng, J. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-039400 · Cited by 5
Use of Machine Learning and Hybrid Closed Loop Insulin Delivery at Diabetes Camps
TAYLOR, K., & Forlenza, G. P. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0026 · Cited by 5
“2,4,6,7 8–10 Although automation has shown early promise to improve glycemic control, AID devices will also require tuning to personalize their control to a given individual and setting.”
Sherr, J. L., Bode, B. W., Forlenza, G. P., Laffel, L. M., Schoelwer, M. J., Buckingham, B. A., Criego, A. B., DeSalvo, D. J., MacLeish, S. A., Hansen, D. W., et al. (2022) · doi:10.2337/figshare.19763350 · Cited by 5
Bai, H., He, N., Zhang, Y., Ahmad, A., Yang, X., Ma, Y., & Liang, L. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s446387 · Cited by 5
AlBurno, H., Schneider, F., de Vries, H., Mohannadi, D. A., Jongen, S., & Mercken, L. A. G. (2025) · Health Psychology Report · doi:10.5114/hpr/194439 · Cited by 4
Pavan, J., Noaro, G., Facchinetti, A., Salvagnin, D., Sparacino, G., & Favero, S. D. (2024) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2024.108179 · Cited by 4
Gaikwad, S. R., Bontha, M. R., Devi, S., & Dumbre, D. (2024) · Public Health Nursing · doi:10.1111/phn.13440 · Cited by 6
Papadakis, J. L., Suhs, M. C., O’Donnell, A. J., Harris, M. A., Anderson, L. M., Garza, K. P., Weil, L. E. G., & Weissberg-Benchell, J. A. (2024) · Children · doi:10.3390/children11111304 · Cited by 4
“Diabetes care and resulting glycemic control are poorly managed during late adolescence and emerging adulthood, making it a high-risk time for individuals with type 1 diabetes (T1D) [1,2].”
RECENT ADVANCES IN TREATMENT APPROACHES FOR DIABETES MELLITUS AND RELATED COMPLICATIONS: A REVIEW
Dhyani, S., Butola, M., Sautha, V., & Jakhmola, V. (2025) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2025v17i2.53184 · Cited by 6
“Various studies have been conducted to assess the overall use of insulin pumps in recent years [115, 116].”
Quality of life in young adults with type 1 diabetes
Baudino, M. N., Carreon, S. A., Streisand, R. M., Tang, T. S., Lyons, S. K., McKay, S. V., Anderson, B. J., Minard, C. G., Devaraj, S., Butler, A. M., et al. (2025) · Health Care Transitions · doi:10.1016/j.hctj.2025.100101 · Cited by 4
Economic Impact of Diabetic Ketoacidosis in the United States
Panjwani, Q., & Bindal, A. (2025) · Diabetes Technology & Therapeutics · doi:10.1177/15209156251390832 · Cited by 4
“32 38 Some of these cases presented with euglycemic DKA (euDKA) in which glucose levels are < 250 mg/dL, 39 which can complicate the diagnosis of DKA, and potentially delay treatment.”
Applying emerging technologies to improve diabetes treatment
Yu, J., Sun, C., Wei, Y., Wang, C., Dave, B., Cao, F., & Hu, L. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.155 · Cited by 4
Liu, F., Li, L., Xu, R. H., Li, X., Xie, Y., & Zhang, H. (2020) · PubMed · doi:10.11817/j.issn.1672-7347.2020.190415 · Cited by 4
Lockhart, D. M., & Smith, D. (2021) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-021-02630-2 · Cited by 4
Diabetes Experiences of Transition from Childhood to Adulthood Care
Nasrabadi, A. N., & Dehkordi, L. M. (2022) · Florence Nightingale Journal of Nursing · doi:10.5152/fnjn.2022.20197 · Cited by 4
“…the care transition also referred to the transition of care from childhood to adulthood as a difficult process that leads to the experience of poor blood sugar control (Dabelea et al., 2017; Lotstein et al., 2013; Lyons et al., 2014; Meleis, 2010; Miller et al., 2015 & Nakhla et al., 2009).”
BackgroundInfluentialWarnick, J. L., Darling, K. E., Topor, L. S., & Jelalian, E. (2023) · Pediatric Diabetes · doi:10.1155/2023/9584419 · Cited by 4
“Adolescents with T1D have the highest average hemoglobin A1C (HbA1C) across the lifespan compared to other age groups due, in large part, to these developmental changes in their physical and psychosocial functioning [12, 13].”
Bowden, N., Dixon, R., Anderson, V. R., de Bock, M. I., Boucsein, A., Kewene-Edwards, M., Gibb, S., Kokaua, J., Palmer, O., Paul, R. G., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-06026-y · Cited by 4
Deng, C., Xie, Y., Liu, F., Tang, X., Li, F., Yang, X., Chen, Y., Zhou, Z., & Li, X. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02357-8 · Cited by 4
Single cell glucose-stimulated insulin secretion assay using nanowell-in-microwell plates
Jang, D., Matthews, K., Deng, P., Berryman, S. G., Nian, C., Duffy, S. P., Lynn, F. C., & Ma, H. (2024) · Lab on a Chip · doi:10.1039/d4lc00413b · Cited by 4
Mukherjee, U. K., Ye, H., & Chhajed, D. (2025) · Journal of Operations Management · doi:10.1002/joom.1363 · Cited by 6
Amor, A. J., Cabrer, M., Giménez, M., Vinagre, I., Ortega, E., & Conget, I. (2016) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2016.08.002 · Cited by 4
La mesure continue du glucose chez l’enfant et l’adolescent
Tubiana‐Rufi, N., & Sierra, P. (2016) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(16)30190-0 · Cited by 4
Hanaire, H. P., Atlan, C., Benhamou, P., Bismuth, É., Bonnemaison, É., Borot, S., Catargi, B., Charpentier, G., Farret, A., Filhol, N., et al. (2017) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(18)30030-0 · Cited by 5
Risk factor control and outpatient attendance in young adults with diabetes
Nadeem, F., Urwin, A., Marshall, M., Doughty, I., Thabit, H., Rutter, M. K., & Leelarathna, L. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1261-5 · Cited by 4
“The USA Type 1 diabetes exchange investigators also evaluated HbA1c data in 2867 individuals aged 18–25 years [5].”
BackgroundRose, L., Kadowaki, T., Pieber, T. R., Buchholtz, K., Ekelund, M., Gorst‐Rasmussen, A., & Philis‐Tsimikas, A. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0608-4 · Cited by 4
Update on Diabetes Medical Management: Epidemiology and Treatment
Chertman, L. S., Neuman, D., & Vendrame, F. (2020) · Springer eBooks · doi:10.1007/978-3-030-33286-0_18 · Cited by 4
Borries, D. V., Patricio Astudillo, P., Perez, V., Hernán García, F., Rumié, K., & Hernán García, B. (2020) · Revista chilena de pediatría · doi:10.32641/rchped.v91i2.1151 · Cited by 4
Shah, V. N., Rewers, A. H., & Garg, S. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816714-4.00013-2 · Cited by 4
20‐year outcomes of childhood‐onset type 1 diabetes: The CANDID incident cohort survey
James, S., Pryke, A., Cusumano, J. M., Jenkins, A. J., Benitez‐Aguirre, P., Craig, M. E., Biggin, A., Lain, S. J., Chan, A. K. F., Nassar, N., et al. (2020) · Diabetic Medicine · doi:10.1111/dme.14473 · Cited by 4
Perceptions of Diabetes Self-Efficacy and Glycemic Control in Youth With Type 1 Diabetes
Shelat, T., Mastrandrea, L. D., Majumdar, I., & Quattrin, T. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0035 · Cited by 5
Role of free style Libre-Flash Glucose Monitoring: Glycemic control of Type-1 Diabetes
Mohamed, I. A. A., Talaat, I. M., Alghamdi, H. A., & Allam, G. A. (2021) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.37.7.4114 · Cited by 4
Irwin, A. K., IGUDESMAN, D. A., Crandell, J., Kichler, J., Kahkoska, A. R., Burger, K. S., Zaharieva, D. P., Addala, A., & Mayer‐Davis, E. J. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13334 · Cited by 6
Wagner, G., Zeiler, M. D., Karwautz, A. F. K., Schneider, A. E., Rami-Merhar, B. M., & Berger, G. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.809015 · Cited by 4
Experiences and real life management of insulin pump therapy in adults with type 1 diabetes
Quirós, C., Jansà, M., Viñals, C., Giménez, M., Roca, D., Escarrabill, J., Garcia, F., Pérez, S., & Conget, I. (2019) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2019.01.004 · Cited by 4
Lal, R., & Leelarathna, L. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.2502 · Cited by 4
“T1D Exchange Registry also shows no increase in DKA rates with pump (8).”
A mechanistic modeling platform of SGLT2 inhibition: Implications for type 1 diabetes
Sokolov, V., Yakovleva, T. A., Stolbov, L. A., Penland, R. C., Boulton, D. W., PARKINSON, J. R., & Tang, W. (2023) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12956 · Cited by 3
Wolf, R. A., Martyn, K. K., HAW, J. S., & Kimble, L. P. (2023) · Western Journal of Nursing Research · doi:10.1177/01939459231172587 · Cited by 4
O’Donnell, H. K., Trojanowski, P. J., Alonso, G. T., Majidi, S., Snell‐Bergeon, J. K., Wadwa, R. P., Vigers, T., Pyle, L. L., Gurka, M. J., Shaffer, E. R., et al. (2023) · Contemporary Clinical Trials · doi:10.1016/j.cct.2023.107270 · Cited by 4
Valdez, R. S., Lyon, S. E., Corbett, J. P., Wellbeloved-Stone, C. A., Hasan, S., Taylor, L. A., DeBoer, M. D., Cherñavvsky, D. R., & Patek, S. D. (2024) · Ergonomics · doi:10.1080/00140139.2024.2343942 · Cited by 4
“…et al. 2008), and recent work has shown how glycemic control significantly declines among individuals within the transitory period to adulthood (Miller et al. 2015, p. 1; Monaghan, helgeson, and Wiebe 2015). studies in the diabetes literature have suggested that there are a range of actors…”
Name, M. A. V., Miller, K. M., COMMISSARIAT, P. V., Whitehouse, A. L., Harrington, K. R., Anderson, B. J., Mantravadi, M., Levy, W. L., DeSalvo, D. J., Tamborlane, W. V., et al. (2019) · Diabetic Medicine · doi:10.1111/dme.14074 · Cited by 4
Self-citationMetabolic and endocrine evaluation of islet transplant function
Rickels, M. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814833-4.00045-9 · Cited by 4
Advantages from “do-it-yourself” loops among children and adolescents in Varna’s Diabetes Center
Bazdarska, Y., Iotova, V., Mladenov, V., Boyadzhiev, V., Stoycheva, R., Galcheva, S., & Bocheva, Y. (2020) · Scripta Scientifica Medica · doi:10.14748/ssm.v51i3.6515 · Cited by 4
Practical Diabetes Technology: Overcoming Barriers in the Real World
Messer, L. H., & WEINZIMER, S. A. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.2511 · Cited by 4
Власенко, І. О. (2021) · Farmatsevtychnyi zhurnal · doi:10.32352/0367-3057.4.21.03 · Cited by 4
Endocrinology research—reflecting on the past decade and looking to the next
Herold, K. C., Majzoub, J. A., Melmed, S. K., Pendergrass, M., & Schlumberger, M. J. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.164 · Cited by 4
Recruitment Into a Pediatric Continuous Glucose Monitoring RCT
Volkening, L. K., Gaffney, K. C., Katz, M. L., & Laffel, L. M. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816656208 · Cited by 4
Fox, L. A., Balkman, E., Englert, K., Hossain, J., & Mauras, N. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12404 · Cited by 4
“Diabetes control often declines during adolescence.(7) Many fac-”
BackgroundMaliszewski, G. A., Patton, S. R., Midyett, L. K., & Clements, M. A. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816664363 · Cited by 5
High Glucose Variability in Hospitalized Patients with Type 1 Diabetes Mellitus
Dadlani, V., Tamhane, S. U., Sun, A.-D., Sharma, A. R., Delivanis, D. A., Thapa, P. B., Carter, R. E., & Kudva, Y. C. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0107 · Cited by 4
Derrick, K. M., & Heptulla, R. A. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818776030 · Cited by 4
Eleftheriadou, I., Didangelos, T., Pappas, A. C., Anastasiou, E., Vasilopoulos, C., Zoupas, C., Manes, C., Tsatsoulis, A. A., Benroubi, M., Pangalos, E., et al. (2019) · HORMONES · doi:10.1007/s42000-019-00153-1 · Cited by 5
Quirós, C., Viñals, C., Giménez, M., Roca, D., & Conget, I. (2019) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2019.03.013 · Cited by 4
Jeter, K. M., Gillaspy, S. R., & Leffingwell, T. R. (2019) · Autism and child psychopathology series · doi:10.1007/978-3-030-21683-2_6 · Cited by 4
Expanding Treatment Options for Improving Health Outcomes in Type 1 Diabetes
Garg, S. K. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.1807 · Cited by 4
Empagliflozin as an adjunctive therapy for type 1 diabetes
MacIsaac, R. J., Lee, M. H., McAuley, S. A., Ward, G. M., & O'Neal, D. N. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.12.52 · Cited by 4
Challenges of Achieving an Optimum Glycemic Control in Children with Type 1 Diabetes in India
Seth, A. (2020) · The Indian Journal of Pediatrics · doi:10.1007/s12098-020-03336-6 · Cited by 5
“Importantly, the control was not worse among the adolescents, another finding reported earlier [6, 7].”
ResultPanfil, K., Redel, J. M., Vandervelden, C. A., Lockee, B., Kahkoska, A. R., Tallon, E. M., Williams, D. D., & Clements, M. A. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241247219 · Cited by 4
“Youth with T1D may experience severe hypoglycemia more often than adults with T1D, 16,22 which may be due in part to increased variability in blood glucose levels, and frequent fluctuations between high and low blood glucose levels may offset any effect of hyperglycemia on HbA1c.”
Oktavian, P., Wungu, C. D. K., Wibisono, S., & Amin, I. M. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.09.198 · Cited by 3
Intermittent fasting to treat diabetes: time to update clinical practice guidelines
Varady, K. A., Chow, L. S., & Peterson, C. M. (2026) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(26)00119-1 · Cited by 3
Campos, L. P., & Lobo, L. M. D. C. (2020) · DEMETRA Alimentação Nutrição & Saúde · doi:10.12957/demetra.2020.43534 · Cited by 3
Hohendorff, J., Kwiatkowska, M., Pisarczyk-Wiza, D., Ludwig‐Słomczyńska, A. H., Milcarek, M., Kapusta, P., Zapała, B., Kieć‐Wilk, B., Trznadel-Morawska, I., Szopa, M., et al. (2021) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16143 · Cited by 3
More hypoglycemia not associated with increasing estimated adiposity in youth with type 1 diabetes
Sarteau, A. C., Kahkoska, A. R., Crandell, J., IGUDESMAN, D. A., Corbin, K. D., Kichler, J., Maahs, D. M., Muntis, F. R., Pratley, R. E., Seid, M., et al. (2022) · Pediatric Research · doi:10.1038/s41390-022-02129-1 · Cited by 3
Self-citationLitmanovitch, E., Geva, R., Leshem, A., Lezinger, M., Heyman, E., Gidron, M., Yarmolovsky, J., Sasson, E., Tal, S., & Rachmiel, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1141085 · Cited by 3
Malova, E., & Harrison, T. R. (2023) · Frontiers in Communication · doi:10.3389/fcomm.2023.1208219 · Cited by 5
Tannus, L. R. M., Pedrosa, H. C., Aguiar, C. H., Drummond, K. R. G., Pinheiro, A., Leal, F. S. L., Negrato, C. A., & Gomes, M. B. (2024) · Primary care diabetes · doi:10.1016/j.pcd.2024.08.001 · Cited by 4
Ketoacidosis in diabetes: Recognition and avoidance
MacArthur, C. (2015) · Practice Nursing · doi:10.12968/pnur.2015.26.8.393 · Cited by 3
Welsh, J. B., Walker, T. C., & Price, D. A. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817694180 · Cited by 3
Price, D. A. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817695341 · Cited by 3
The First Hybrid Closed-Loop Insulin Pump: Will It Meet Its Potential?
Hirsch, I. B. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0045 · Cited by 3
Change in hemoglobin A1c one year following the 2014 American Diabetes Association guideline update
Alonso, G. T., Pyle, L. L., & Frohnert, B. I. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.03.033 · Cited by 3
LaBarbera, B., Dvorak, J., Zhang, Y., Jeter, K. M., Talsania, M., & Beck, J. K. (2019) · Psychology Health & Medicine · doi:10.1080/13548506.2019.1597976 · Cited by 3
Tetzschner, R., Ranjan, A. G., Schmidt, S., & Nørgaard, K. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-00696-x · Cited by 3
Casagrande, S. S., Lessem, S. E., Orchard, T. J., Bullard, K. M., Geiss, L. S., Saydah, S., Menke, A., Imperatore, G., Rust, K., & Cowie, C. C. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001917 · Cited by 3
“4 13 Given the various definitions used to classify type 1 diabetes using survey data and the lack of a gold standard, we examined the percentages of adults with diagnosed diabetes classified as having type 1 diabetes in the NHIS, using five primary and two supplementary algorithms, included for…”
Dental Treatment Effect on Blood Glucose Level Fluctuation in Type 1 Balanced Diabetic Children
Nassif, N., & Noueiri, B. (2021) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1907 · Cited by 4
Chai, T. Y., Farrell, K., & Holmes-Walker, D. J. (2021) · Internal Medicine Journal · doi:10.1111/imj.15539 · Cited by 3
Planalp, E. M., Kliems, H., Chewning, B. A., Palta, M., LeCaire, T. J., Young, L., & COX, E. D. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002583 · Cited by 3
Structured transition is associated with improved outcomes in diabetes
Harmer, M., Everitt, L. H., Parker, L., Davis, N. L., Connett, G. J., & Nagra, A. (2022) · Practical Diabetes · doi:10.1002/pdi.2375 · Cited by 3
Ali, N., Longson, J., Myszka, R., Park, K., Low, G. K. K., Leong, G. M., Bhurawala, H., & Liu, A. (2021) · Journal of Transition Medicine · doi:10.1515/jtm-2021-0003 · Cited by 4
“There are studies that have expressed the transfer to adult care may be accompanied by poor glycemic control and decreased clinic attendances [1, 2].”
BackgroundRestoring tolerance to β-cells in Type 1 diabetes: Current and emerging strategies
Carroll, K. R., & Katz, J. D. (2022) · Cellular Immunology · doi:10.1016/j.cellimm.2022.104593 · Cited by 4
Addison, J., Razzaghi, H., Bailey, L. C., Dickinson, K., Corathers, S. D., Hartley, D., Utidjian, L., Carle, A. C., Rhodes, E. T., Alonso, G. T., et al. (2022) · Pediatric Quality and Safety · doi:10.1097/pq9.0000000000000602 · Cited by 3
Mapping care provision for type 1 diabetes throughout Australia: a protocol for a mixed-method study
Carrigan, A., Lake, R., Zoungas, S., Huynh, T., Couper, J., Davis, E. A., Jones, T. W., Bloom, D. E., Braithwaite, J., & Zurynski, Y. A. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-067209 · Cited by 3
Madsen, T. V., Cooper, J. G., Carlsen, S., Løvaas, K. F., Rekdal, M., Igland, J., Sandberg, S., Ueland, G. Å., Iversen, M. M., & Sølvik, U. Ø. (2023) · BMJ Open Quality · doi:10.1136/bmjoq-2022-002099 · Cited by 3
Berg, C. A., Tracy, E. L., Boggess, S. B., Butner, J., Loyola, M. D. R., & Wiebe, D. J. (2023) · Journal of Behavioral Medicine · doi:10.1007/s10865-023-00425-7 · Cited by 3
“Stress reactivity experienced in emerging adulthood together with challenges in keeping HbA1c on target (Miller et al., 2015) could place young adults at higher risk for long-term complications like blood vessel, kidney, and heart disease.”
Prevention of Type 1 Diabetes: Current Perspective
Pande, A. K., Dutta, D., & Singla, R. (2023) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_78_23 · Cited by 6
“[9] Therapies of T1D are becoming better and more efficacious with time, it still involves a lot of effort and expenditure (out of pocket in the case of India).”
BackgroundBurkhardt, M. S., Pirri, C., Summers, M. A., Barrie, P., Aghabozorgi, M., Fegan, P. G., & Yeap, B. B. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111095 · Cited by 4
Weisman, A., Booth, G. L., Everett, K., & TOMLINSON, G. A. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0017 · Cited by 5
Eroukhmanoff, J., Schmit, C. B., Baron, S., Bahloul, A., Beltrand, J., Salamé, Z., Borot, S., Vale, F. D., Mosnier-Pudar, H., Nicolino, M. P., et al. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01630-6 · Cited by 3
Carrigan, A., Holmes-Walker, D. J., Farrell, K., Maguire, A., Lyng, H. B., Wiig, S., Guise, V., Long, J. C., Ellis, L. A., Wijekulasuriya, S., et al. (2024) · Applied Ergonomics · doi:10.1016/j.apergo.2024.104392 · Cited by 3
“Although individuals living with T1D typically understand these risks and the importance of maintaining glycemic control, registries show that less than 20% are able to achieve recommended glycemic targets (Holmes-Walker et al., 2023; Miller et al., 2015; Phelan et al., 2017).”
InfluentialJohansen, N. J., Dejgaard, T. F., Lund, A., Vilsbøll, T., Andersen, H. U., & Knop, F. K. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-021861 · Cited by 3
‘La Vida Normal’: Young people adapting to Type 1 diabetes in Bolivia
Souris, K. J., Gonzales, M. D. C. C., Barrington, C., Klatman, E. L., Anderson, B. J., Duarte, E. D. R., Middlehurst, A. C., Nostas, M. C., & Ogle, G. D. (2019) · Chronic Illness · doi:10.1177/1742395319843172 · Cited by 4
“Other studies have supported the resentment, anger, and depression that often accompany diagnosis and life with T1D, especially for young people.31–33 Emotional distress and elevated glycaemia can operate in a vicious cycle, each exacerbating the other.34,35 Additionally, experienced and perceived stigma has been asso…”
ResultO’Donnell, H. K., & Driscoll, K. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816000-8.00003-7 · Cited by 4
Zhao, X., Hilton, A., Watson, R. A., & Chen, Y. (2021) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2021.03.029 · Cited by 3
Wan, W., Nathan, A. G., Reid, M. W., Majidi, S., Fogel, J. L., Raymond, J. K., & Huang, E. S. (2022) · Journal of Pediatric Health Care · doi:10.1016/j.pedhc.2022.05.007 · Cited by 3
Sensor Life and Overnight Closed Loop: A Randomized Clinical Trial
Tauschmann, M., Allen, J. M., Wilinska, M. E., Ruan, Y., Thabit, H., Acerini, C. L., Dunger, D. B., & Hovorka, R. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816678631 · Cited by 3
“CGM is becoming increasingly popular in people with type 1 diabetes across all age-groups.(1) Clinical benefits, particularly in combination with insulin pump therapy, are conditioned on good adherence.”
Background
Metadata
- Authors
- Miller, K. M., Foster, N. C., Beck, R. W., Bergenstal, R. M., DuBose, S. N., DiMeglio, L. A., Maahs, D. M., & Tamborlane, W. V.
- Affiliations
- Jaeb Center for Health Research (US)
- Park Nicollet Health Services (US)
- Indiana University School of Medicine (US)
- Barbara Davis Center for Childhood Diabetes, Aurora, CO
- Yale University (US)
- Corresponding author
- Miller, Kellee M.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2015-05-12
- Volume
- 38
- Issue
- 6
- Pages
- 971-978
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2098570086
- Cited by
- 1,254
- References
- 25
- Citations by year
- 2026: 35 · 2025: 55 · 2024: 64 · 2023: 88 · 2022: 81 · 2021: 134 · 2020: 157 · 2019: 198 · 2018: 176 · 2017: 138 · 2016: 108 · 2015: 19
- FWCI
- 127.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Leona M. and Harry B. Helmsley Charitable Trust
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- type 1 diabetes, glycemic control, HbA1c, severe hypoglycemia, diabetic ketoacidosis, insulin pump therapy, continuous glucose monitoring, diabetes technology, age trends
- MeSH terms
- Adolescent, Adult, Aged, Child, Child, Preschool, Diabetes Mellitus, Type 1, Health Services Needs and Demand, Glycated Hemoglobin, Humans, Insulin Infusion Systems, Male, Middle Aged, Registries, United States, Blood Glucose Self-Monitoring, Comorbidity, Diabetic Ketoacidosis, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review